Other Events ·
PMGC Holdings Inc.'s subsidiary NorthStrive Biosciences executed a First Amendment to its Development and License…
ELABPMGC Holdings Inc.
PMGC Holdings Inc.'s subsidiary NorthStrive Biosciences executed a First Amendment to its Development and License Agreement with Yuva Biosciences, launching a three-phase Expansion Program to advance four AI-discovered compounds toward lead nomination for Cardiac Diseases and Obesity. The amendment updates the program scope, intellectual property framework, field of use definitions, and financial terms. Concurrently, PMGC filed a Certificate of Amendment to its Articles of Incorporation on August 31, 2026, increasing authorized capital stock to 1,500,000,000 shares, comprising 1,000,000,000 common and 500,000,000 preferred shares. This filing was approved by shareholders holding 60.34% of voting power. PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries.